I attended and my opinion was nothing new other than reiterating the timeline for AMP945 application for idiopathic pulmonary fibrosis + pancreatic cancer regarding trials and data collection etc. Majority was spent voting on agenda items. There was no set time provided at the end for asking questions which i found odd. Not sure if this is normal now we are using zoom. Dr Lambert read off a a script most of the time. Market seems to have reacted well though.
Ann: CEO Presentation to AGM, page-4
Add ATX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
6.7¢ |
Change
-0.001(1.47%) |
Mkt cap ! $18.19M | |||
| Open | High | Low | Value | Volume |
| 6.7¢ | 7.0¢ | 6.7¢ | $95 | 1.411K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 12728 | 6.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 7.0¢ | 21327 | 1 |
View Market Depth
| Last trade - 15.59pm 14/06/2024 (20 minute delay) ? |
|
|||||
|
Last
6.9¢ |
Change
-0.001 ( 1.47 %) |
||||
| Open | High | Low | Volume | ||
| 6.7¢ | 6.9¢ | 6.7¢ | 333 | ||
| Last updated 15.48pm 14/06/2024 ? | |||||
| ATX (ASX) Chart |